SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Welcome to the GENT board. GENT has the first drug for VOD.
An SI Board Since July 2006
Posts SubjectMarks Bans Symbol
408 17 0 GENT
Emcee:  rareearth42 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
308Brean raises PT to 60IRWIN JAMES FRANKEL-10/22/2013
307Gentium Receives Marketing Authorization From the European Commission for DefiteIRWIN JAMES FRANKEL-10/22/2013
306Gentium Receives Positive Opinion From EMA's COMP for Defibrotide for the PrIRWIN JAMES FRANKEL-10/10/2013
305Brean raised PT to 38 I am raising my PT too. :-)IRWIN JAMES FRANKEL-10/7/2013
304WB target to 35. 2014 eps raised ~$1.87 2015 eps raised ~$3.94IRWIN JAMES FRANKEL-9/30/2013
303mobile.bcshguidelines.comIRWIN JAMES FRANKEL-9/19/2013
302nottinghamresearch • 5 hours ago 0 users liked this postsusers disliked thisIRWIN JAMES FRANKEL-9/19/2013
301Nottingham again: seekingalpha.comIRWIN JAMES FRANKEL-9/9/2013
300A tweet yesterday: Bill Gunderson ?@billgunderson17h We added a new stock to thIRWIN JAMES FRANKEL-9/5/2013
299You don't?tom pope-9/3/2013
298And there was a buyer too. She had filed to sell the block so good to know it iIRWIN JAMES FRANKEL-9/3/2013
297fwiw, the 300k share block, or so I am told, was from the former CEO Miss Ferro.rkrw-9/3/2013
296I sometimes think the phrase "profit taking" has little meaning, but ttom pope-9/3/2013
295Two blocks of 300k and 150k at 18.45IRWIN JAMES FRANKEL-9/3/2013
294SA article: Gentium: Buying Opportunity At A Lower Level Amid Correction [$15.IRWIN JAMES FRANKEL-8/30/2013
293FMR reduced by 340K Still some not updated to 6/30 nasdaq.comIRWIN JAMES FRANKEL-8/16/2013
292Per Twitter - Brean raised PT to 24 Blackrock raised holdings to 4.6M shares upIRWIN JAMES FRANKEL-8/14/2013
291Gentium's CEO Discusses Q2 2013 Results - Earnings Call Transcript Aug 13 2IRWIN JAMES FRANKEL-8/13/2013
290Gentium's CEO Discusses Q2 2013 Results - Earnings Call Transcript Aug 13 2IRWIN JAMES FRANKEL-8/13/2013
289GENT EPS for 2Q $0.16* vs. avg analyst estimate of $0.04, high analyst at $0.06.IRWIN JAMES FRANKEL-8/13/2013
288Gentium Reports First Half 2013 Financial Results [graphic]Press Release: GentiuIRWIN JAMES FRANKEL-8/13/2013
287Very neat idea, Peter. We know they are after GvHD, targeting ST2 makes sense. IRWIN JAMES FRANKEL-8/9/2013
286>GENT [taken from IH by Peter] Well obviously if they ran a successful prevIRWIN JAMES FRANKEL-8/9/2013
285seekingalpha.com Gentium: An Undervalued Orphan Biotech Aug 8 2013, 10:49 | IRWIN JAMES FRANKEL-8/8/2013
284>>Wish they would webcast their presentations next one they are listed as IRWIN JAMES FRANKEL-8/6/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News